Omaveloxolone: a groundbreaking milestone as the first FDA-approved drug for Friedreich ataxia
Article in Trends in Molecular Medicine (January 2024)
The most recent citing publications are shown below. View all 72 publications that cite this research output on Dimensions.
Friedreich Ataxia
Book chapter (March 2023)
History of Ataxias and Paraplegias with an Annotation on the First Description of Striatonigral Degeneration
Article in The Cerebellum (November 2021)